The latest report published by IMARC Group, titled “Europe Biopsy Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, offers a comprehensive analysis of the industry, which comprises insights on the Europe biopsy devices market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Industry Definition and Application:
Biopsy devices are diagnostic tools widely utilized to detect breast, skin, prostate, and other kinds of cancer. These devices help acquire tissue samples of the diseased part of the patient presumed to have cancer. Biopsy devices are increasingly used by surgeons, radiologists, and interventional cardiologists to perform procedures on body organs such as the lungs, liver, skin and kidneys. The usage of biopsy devices varies according to the type of organ under consideration. Earlier, conventional biopsy devices were used, including aspiration needles, forceps, and localization wires. However, advanced imaging technologies are used nowadays, which help in performing the biopsy with minimal invasiveness and higher accuracy. As a result, they find application in healthcare institutions, medical clinics, and diagnostic centers.
Market Trends and Growth Drivers:
The market is primarily driven by the increasing incidences of cancer and the rising geriatric population across Europe. Besides this, the growing awareness regarding the need for early diagnosis of chronic diseases is propelling the demand for integrated biopsy technologies. As a result, individuals are opting for minimally invasive treatment due to comparatively less pain and a faster recovery rate. In addition to this, the European Union (EU) is undertaking initiatives to uplift the healthcare sector in the region. For instance, the European Union’s Horizon 2020 program rewarded €6.3 Million for magnetic resonance imaging (MRI) research and liquid biopsy. They are also extensively investing in procuring high-quality medical tools and devices like biopsy devices. Furthermore, the advancements in healthcare infrastructure and inflating disposable incomes of individuals are positively impacting the market growth.
Key Market Segmentation:
The report has segmented the Europe biopsy devices market based on procedure type, product, application, guidance technique, end user and country.
Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
- Ultrasound-guided Biopsy
- Stereotactic-guided Biopsy
- MRI-guided Biopsy
- Others
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitive Analysis:
The competitive landscape of the Europe biopsy devices market has been studied in the report with the detailed profiles of the key players operating in the market.
Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/europe-biopsy-devices-market
Key Highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: [email protected]
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/